CUPR vs PAHC

For growth investors, Phibro Animal Health Corporation (PAHC) is the stronger pick with 27.

4% revenue growth year-over-year, versus -52. 0% for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR). Phibro Animal Health Corporation (PAHC) offers the better valuation at 49. 3x trailing P/E (19. 3x forward), making it the more compelling value choice. Analysts rate Phibro Animal Health Corporation (PAHC) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Phibro Animal Health Corporation (PAHC) delivered a total return of +136.

4%, compared to -93. 7% for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR). Over 10 years, the gap is even starker: PAHC returned +207. 3% versus CUPR's -93. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is the lower-risk stock at 0.

02β versus Phibro Animal Health Corporation's 1. 38β — meaning PAHC is approximately 5438% more volatile than CUPR relative to the S&P 500.

By revenue growth (latest reported year), Phibro Animal Health Corporation (PAHC) is pulling ahead at 27.

4% versus -52. 0% for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR). On earnings-per-share growth, the picture is similar: Phibro Animal Health Corporation grew EPS 1883% year-over-year, compared to -39. 2% for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares. Over a 3-year CAGR, PAHC leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Phibro Animal Health Corporation (PAHC) is the more profitable company, earning 3.

7% net margin versus -32. 3% for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares — meaning it keeps 3. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PAHC leads at 8. 5% versus -34. 0% for CUPR. At the gross margin level — before operating expenses — PAHC leads at 30. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, PAHC (0.

8% yield) pays a dividend. CUPR does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

02)). Both have compounded well over 10 years (CUPR: -93. 7%, PAHC: +207. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CUPR is a small-cap quality compounder stock; PAHC is a small-cap high-growth stock. PAHC pays a dividend while CUPR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.